Diabetes, Vol 46, Issue 4 557-564, Copyright © 1997 by American Diabetes Association

ARTICLES

Immunological aspects of nutritional diabetes prevention in NOD mice: a pilot study for the cow's milk-based IDDM prevention trial

W Karges, D Hammond-McKibben, RK Cheung, M Visconti, N Shibuya, D Kemp and HM Dosch
Department of Pediatrics, Research Institute, University of Toronto, Canada.

Human epidemiological studies delineated early exposure to intact dietary protein (e.g., most infant formulas) as an environmental risk factor for the development of IDDM. The Trial to Reduce IDDM in the Genetically at Risk (TRIGR), an international IDDM prevention trial, has been designed to determine if avoidance of intact dairy protein in high-risk infants < or =6 months of age can reduce the subsequent diabetes incidence. We here studied the casein hydrolysate-based trial diet (Nutramigen) in NOD mice. When given either continuously or for 10 weeks after weaning, the test diet was highly effective in preventing autoimmune diabetes (32-week incidence: 4.6 vs. 58.8%) and in preserving pancreatic insulin levels, with little effect on islet inflammation. Spleen cells from protected NOD mice failed to adoptively transfer diabetes into irradiated syngeneic recipients. When co-transferred with splenocytes from diabetic donors, cells from diet-protected mice inhibited adoptive diabetes transfer (incidence 50 vs. 94%, P < 0.001). T-cell reactivity to the islet cell autoantigens ICA69 (islet cell antigen 69) and GAD65 developed only in diabetic recipients of spleen cell grafts, indicating that diabetes protection extends to more than one autoantigen. In protected mice, ICA69 T-cell reactivity was not detectable spontaneously nor after priming with this autoantigen; however, priming with the cross-reactive non-self-antigen bovine serum albumin recruited T-cells responsive to ICA69. Thus, diabetes prevention with the clinical trial diet is effective in NOD mice, where it affects some T-cell repertoires and allows development of regulatory cells that interfere with destructive autoimmunity.
CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				R. A. Caicedo, N. Li, M. A. Atkinson, D. A. Schatz, and J. Neu Neonatal Nutritional Interventions in the Prevention of Type 1 Diabetes NeoReviews, May 1, 2005; 6(5): e220 - e226. [Full Text] [PDF]

				S Graham, P Courtois, W J Malaisse, J Rozing, F W Scott, and A M. I Mowat Enteropathy precedes type 1 diabetes in the BB rat Gut, October 1, 2004; 53(10): 1437 - 1444. [Abstract] [Full Text] [PDF]

				A. J. MacFarlane, K. M. Burghardt, J. Kelly, T. Simell, O. Simell, I. Altosaar, and F. W. Scott A Type 1 Diabetes-related Protein from Wheat (Triticum aestivum). cDNA CLONE OF A WHEAT STORAGE GLOBULIN, Glb1, LINKED TO ISLET DAMAGE J. Biol. Chem., January 3, 2003; 278(1): 54 - 63. [Abstract] [Full Text] [PDF]

				L. F. Ross Minimizing Risks: The Ethics of Predictive Diabetes Mellitus Screening Research in Newborns Arch Pediatr Adolesc Med, January 1, 2003; 157(1): 89 - 95. [Abstract] [Full Text] [PDF]

				W. Karges, K. Pechhold, S. Al Dahouk, I. Riegger, M. Rief, A. Wissmann, R. Schirmbeck, C. Barth, and B. O. Boehm Induction of Autoimmune Diabetes Through Insulin (but Not GAD65) DNA Vaccination in Nonobese Diabetic and in RIP-B7.1 Mice Diabetes, November 1, 2002; 51(11): 3237 - 3244. [Abstract] [Full Text] [PDF]

				S. Winer, I. Astsaturov, R. Gaedigk, D. Hammond-McKibben, M. Pilon, A. Song, V. Kubiak, W. Karges, E. Arpaia, C. McKerlie, et al. ICA69null Nonobese Diabetic Mice Develop Diabetes, but Resist Disease Acceleration by Cyclophosphamide J. Immunol., January 1, 2002; 168(1): 475 - 482. [Abstract] [Full Text] [PDF]

				S. Winer, I. Astsaturov, R. K. Cheung, K. Schrade, L. Gunaratnam, D. D. Wood, M. A. Moscarello, P. O'Connor, C. McKerlie, D. J. Becker, et al. T Cells of Multiple Sclerosis Patients Target a Common Environmental Peptide that Causes Encephalitis in Mice J. Immunol., April 1, 2001; 166(7): 4751 - 4756. [Abstract] [Full Text] [PDF]

				S. Winer, L. Gunaratnam, I. Astsatourov, R. K. Cheung, V. Kubiak, W. Karges, D. Hammond-McKibben, R. Gaedigk, D. Graziano, M. Trucco, et al. Peptide Dose, MHC Affinity, and Target Self-Antigen Expression Are Critical for Effective Immunotherapy of Nonobese Diabetic Mouse Prediabetes J. Immunol., October 1, 2000; 165(7): 4086 - 4094. [Abstract] [Full Text] [PDF]

				I. Thorsdottir, B. E. Birgisdottir, I. M. Johannsdottir, D. P. Harris, J. Hill, L. Steingrimsdottir, and A. V. Thorsson Different beta -Casein Fractions in Icelandic Versus Scandinavian Cow's Milk May Influence Diabetogenicity of Cow's Milk in Infancy and Explain Low Incidence of Insulin-Dependent Diabetes Mellitus in Iceland Pediatrics, October 1, 2000; 106(4): 719 - 724. [Abstract] [Full Text]

				D. J. Becker, R. E. LaPorte, I. Libman, M. Pietropaolo, and H.-M. Dosch Prevention of Type 1 Diabetes: Is Now the Time? J. Clin. Endocrinol. Metab., February 1, 2000; 85(2): 498 - 506. [Full Text]